Evidence map›Paper›PMID 36895019›Full record

ArticleAlzheimer's research & therapy2023

Assessment of Alzheimer-related pathologies of dementia using machine learning feature selection.

Mohammed D Rajab, Emmanuel Jammeh, Teruka Taketa, Carol Brayne, Fiona E Matthews, Li Su, Paul G Ince, Stephen B Wharton, Dennis Wang, Cognitive Function and Ageing Neuropathology Study Group

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Mohammed D RajabSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK.
Emmanuel JammehSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK.
Teruka TaketaSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK.
Carol BrayneCambridge Public Health, Cambridge, CB2 1PZ, UK.
Fiona E MatthewsPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Li SuSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK.
Paul G InceSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK.
Stephen B WhartonSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK.
Dennis WangSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK. dennis.wang@imperial.ac.uk.
Cognitive Function and Ageing Neuropathology Study Group
University of Sheffield · GBLung Institute · USNewcastle University · GBUniversity of Cambridge · GB

Funding

Department of HealthMedical Research Council G0900582Medical Research Council G9901400Medical Research Council MRC/G9901400Medical Research Council U.1052.00.0013
6 · The paper itself

Abstract

Although a variety of brain lesions may contribute to the pathological assessment of dementia, the relationship of these lesions to dementia, how they interact and how to quantify them remains uncertain. Systematically assessing neuropathological measures by their degree of association with dementia may lead to better diagnostic systems and treatment targets. This study aims to apply machine learning approaches to feature selection in order to identify critical features of Alzheimer-related pathologies associated with dementia. We applied machine learning techniques for feature ranking and classification to objectively compare neuropathological features and their relationship to dementia status during life using a cohort (n=186) from the Cognitive Function and Ageing Study (CFAS). We first tested Alzheimer's Disease and tau markers and then other neuropathologies associated with dementia. Seven feature ranking methods using different information criteria consistently ranked 22 out of the 34 neuropathology features for importance to dementia classification. Although highly correlated, Braak neurofibrillary tangle stage, beta-amyloid and cerebral amyloid angiopathy features were ranked the highest. The best-performing dementia classifier using the top eight neuropathological features achieved 79% sensitivity, 69% specificity and 75% precision. However, when assessing all seven classifiers and the 22 ranked features, a substantial proportion (40.4%) of dementia cases was consistently misclassified. These results highlight the benefits of using machine learning to identify critical indices of plaque, tangle and cerebral amyloid angiopathy burdens that may be useful for classifying dementia.

Indexed as

Alzheimer DiseaseCerebral Amyloid AngiopathyAmyloid beta-PeptidesBrainHumansMachine LearningNeurofibrillary TanglesAmyloid beta-PeptidesAlzheimer’sBeta-amyloidDementiaFeature selectionMachine learningNeuropathology

Identifiers

PMID36895019
PMCPMC9999590
OpenAlexW4323809088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.